Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cappellini

Showing results (731-740 of 863) with videos related to

Pageof 87
Sort By:
Oncotarget|December 29, 2012
A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemiaFrancesca Chiarini, Annalisa Lonetti, Gabriella Teti, et al.
BMJ Open|November 14, 2024
Identifying thresholds for meaningful improvements in NTDT-PRO scores to support conclusions about treatment benefit in clinical studies of patients with non-transfusion-dependent beta-thalassaemia: analysis of pooled data from a phase 2, double-blind, placebo-controlled, randomised trialAli T Taher, Khaled M Musallam, Vip Viprakasit, et al.
Cellular and Molecular Life Sciences : CMLS|October 9, 2020
Cell signaling pathways in autosomal-dominant leukodystrophy (ADLD): the intriguing role of the astrocytesStefano Ratti, Isabella Rusciano, Sara Mongiorgi, et al.
EMBO Molecular Medicine|July 29, 2010
Correction of beta-thalassemia major by gene transfer in haematopoietic progenitors of pediatric patientsEmanuela Anna Roselli, Riccardo Mezzadra, Marta Claudia Frittoli, et al.
Leukemia|March 5, 2010
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanismsA M Martelli, V Papa, P L Tazzari, et al.
Blood Transfusion = Trasfusione Del Sangue|November 16, 2020
Changing patterns of thalassaemia in Italy: a WebThal perspectiveFilomena Longo, Paola Corrieri, Raffaella Origa, et al.
American Journal of Hematology|January 2, 2023
Overall and complication-free survival in a large cohort of patients with β-thalassemia major followed over 50 yearsGian Luca Forni, Barbara Gianesin, Khaled M Musallam, et al.
Recenti Progressi in Medicina|October 14, 2021
[Management of small cell lung cancer patient in the regions of Lazio, Umbria and Sardinia.]Gabriele Minuti, Alessio Stefani, Silvia Carpano, et al.
British Journal of Haematology|May 11, 2012
Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label studyGian Luca Forni, Silverio Perrotta, Andrea Giusti, et al.
Gastrointestinal Endoscopy|March 15, 2026
DIAGNOSTIC YIELD AND USEFULNESS OF TERMINAL ILEAL INTUBATION IN ASYMPTOMATIC PATIENTS UNDERGOING COLONOSCOPY FOR COLORECTAL CANCER SCREENING OR POST-POLYPECTOMY SURVEILLANCE: A SYSTEMATIC REVIEW AND META-ANALYSISDavide Scalvini, Stiliano Maimaris, Alessandro Cappellini, et al.
Pageof 87

Showing results (731-740 of 863) with videos related to

Sort By:
Pageof 87
Oncotarget|December 29, 2012
A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemiaFrancesca Chiarini, Annalisa Lonetti, Gabriella Teti, et al.
BMJ Open|November 14, 2024
Identifying thresholds for meaningful improvements in NTDT-PRO scores to support conclusions about treatment benefit in clinical studies of patients with non-transfusion-dependent beta-thalassaemia: analysis of pooled data from a phase 2, double-blind, placebo-controlled, randomised trialAli T Taher, Khaled M Musallam, Vip Viprakasit, et al.
Cellular and Molecular Life Sciences : CMLS|October 9, 2020
Cell signaling pathways in autosomal-dominant leukodystrophy (ADLD): the intriguing role of the astrocytesStefano Ratti, Isabella Rusciano, Sara Mongiorgi, et al.
EMBO Molecular Medicine|July 29, 2010
Correction of beta-thalassemia major by gene transfer in haematopoietic progenitors of pediatric patientsEmanuela Anna Roselli, Riccardo Mezzadra, Marta Claudia Frittoli, et al.
Leukemia|March 5, 2010
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanismsA M Martelli, V Papa, P L Tazzari, et al.
Blood Transfusion = Trasfusione Del Sangue|November 16, 2020
Changing patterns of thalassaemia in Italy: a WebThal perspectiveFilomena Longo, Paola Corrieri, Raffaella Origa, et al.
American Journal of Hematology|January 2, 2023
Overall and complication-free survival in a large cohort of patients with β-thalassemia major followed over 50 yearsGian Luca Forni, Barbara Gianesin, Khaled M Musallam, et al.
Recenti Progressi in Medicina|October 14, 2021
[Management of small cell lung cancer patient in the regions of Lazio, Umbria and Sardinia.]Gabriele Minuti, Alessio Stefani, Silvia Carpano, et al.
British Journal of Haematology|May 11, 2012
Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label studyGian Luca Forni, Silverio Perrotta, Andrea Giusti, et al.
Gastrointestinal Endoscopy|March 15, 2026
DIAGNOSTIC YIELD AND USEFULNESS OF TERMINAL ILEAL INTUBATION IN ASYMPTOMATIC PATIENTS UNDERGOING COLONOSCOPY FOR COLORECTAL CANCER SCREENING OR POST-POLYPECTOMY SURVEILLANCE: A SYSTEMATIC REVIEW AND META-ANALYSISDavide Scalvini, Stiliano Maimaris, Alessandro Cappellini, et al.
Pageof 87